双侧输卵管切除术联合延迟卵巢切除术降低卵巢癌风险:BRCA1/2突变女性的先导研究
这项前瞻性、多中心、非随机先导研究纳入30至47岁绝经前BRCA1/2突变携带者,受试者选择筛查、降低风险的输卵管卵巢切除术(RRSO)或双侧输卵管切除术联合延迟卵巢切除术(BS/DO)。43例中19例(44%)选择BS/DO、12例(28%)选择RRSO、12例(28%)选择筛查;术后12个月BS/DO组癌症担忧评分下降(P<0.0001),RRSO组亦下降(P=0.01),BS/DO组状态焦虑量表评分较术前下降(P=0.02)。
要点
- 43例BRCA1/2突变携带者中19例(44%)选择BS/DO,12例(28%)选择RRSO,12例(28%)选择筛查。
- RRSO患者中发现1例浆液性输卵管上皮内癌(STIC),未发现隐匿性卵巢癌,无手术并发症。
- 术后12个月BS/DO组癌症担忧评分下降(P<0.0001),状态焦虑评分较术前下降(P=0.02)。
核心结论
- 在这项先导研究中,接受双侧输卵管切除术的BRCA突变携带者无术中并发症,对手术选择满意,术后癌症担忧和焦虑减轻。
研究设计与样本
- 前瞻性、多中心、非随机先导研究,纳入30至47岁绝经前BRCA1/2突变携带者,受试者选择筛查、RRSO或BS/DO。
- BS/DO组中,BRCA1患者推荐在40岁、BRCA2患者在45岁行延迟卵巢切除术。
- 共纳入43例患者,其中BRCA1携带者占37%,BRCA2携带者占63%。
主要发现
- 43例中19例(44%)选择BS/DO,12例(28%)选择RRSO,12例(28%)选择筛查。
- 1例RRSO患者发现浆液性输卵管上皮内癌(STIC),未发现隐匿性卵巢癌病例,无手术并发症。
- 术后12个月,癌症担忧量表评分在BS/DO组下降(P<0.0001)、在RRSO组下降(P=0.01)。
- 术后12个月,状态焦虑量表评分在BS/DO组较术前下降(P=0.02)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Risk-reducing salpingo-oophorectomy (RRSO) reduces ovarian cancer risk in BRCA1/2 mutation carriers, but the adverse effects of the associated early-onset surgical menopause are problematic. Despite suggestive evidence, no data demonstrate whether bilateral salpingectomy alone lowers the risk of developing ovarian cancer in BRCA mutation carriers. We conducted a pilot study of bilateral salpingectomy with delayed oophorectomy (BS/DO) in BRCA mutation carriers to determine the safety and acceptability of the procedure. METHODS: In this prospective, multicenter, non-randomized pilot study, pre-menopausal BRCA1/2 mutation carriers aged 30 to 47 years chose screening, RRSO, or BS/DO. For those undergoing BS/DO, the delayed oophorectomy was recommended at age 40 years for BRCA1 and age 45 years for BRCA2 patients. We compared surgical and psychosocial outcomes between time points and between arms. RESULTS: Of the 43 patients enrolled, 19 (44%) chose BS/DO, 12 (28%) chose RRSO, and 12 (28%) chose screening. The cohort was 37% BRCA1 carriers and 63% BRCA2 carriers. One serous tubal intraepithelial carcinoma (STIC) was found in an RRSO patient, and no cases of occult ovarian cancers were found. There were no surgical complications. Twelve months after surgery, responses on the Cancer Worry Scale indicated decreased worry in the BS/DO (P < 0.0001) and RRSO (P = 0.01) arms, while responses on the State Anxiety Inventory indicated decreased anxiety in the BS/DO arm (P = 0.02) compared with preoperative responses. CONCLUSIONS: In this pilot study, BRCA mutation carriers who underwent bilateral salpingectomy had no intraoperative complications, were satisfied with their procedure choice, and had decreased cancer worry and anxiety after the procedure.
引用
- Nebgen DR, Hurteau J, Holman LL, et al. Bilateral salpingectomy with delayed oophorectomy for ovarian cancer risk reduction: A pilot study in women with BRCA1/2 mutations. Gynecol Oncol. 2018. PMID: 29735278. doi:10.1016/j.ygyno.2018.04.564
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。